Working… Menu
Trial record 1 of 2 for:    NCT00103662
Previous Study | Return to List | Next Study

Long-Term Follow-up Study for Multiple Myeloma Patients Who Received Study Treatment (Plerixafor or Placebo) in the AMD3100-3102 Study (NCT00103662).

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00741780
Recruitment Status : Completed
First Posted : August 26, 2008
Last Update Posted : March 24, 2015
Information provided by (Responsible Party):
Sanofi ( Genzyme, a Sanofi Company )